Well Lead(SH:603309) Sou Hu Cai Jing·2025-10-19 20:12Core Viewpoint - The company, Weili Medical, is set to repurchase and cancel 996,600 restricted stocks due to unmet performance targets, resulting in a reduction of its total share capital by October 22, 2025 [2][3]. Trading Information Summary - On October 17, 2025, Weili Medical's stock closed at 13.21 yuan, down 1.49%, with a turnover rate of 1.0%, trading volume of 29,100 shares, and a transaction value of 38.6875 million yuan [1]. - On the same day, the net outflow of main funds was 1.907 million yuan, accounting for 4.93% of the total transaction value, while retail investors saw a net inflow of 3.2 million yuan, representing 8.27% of the total transaction value [1][3]. Company Announcement Summary - Weili Medical's decision to repurchase and cancel 996,600 restricted stocks affects 77 incentive recipients, with 990,000 stocks being fully canceled due to unmet performance criteria for the third release period, and 6,600 stocks canceled from the second release period [2]. - The repurchase price for the first grant is adjusted to 5.55 yuan per share, while the reserved grant is set at 5.27 yuan per share, funded by the company's own resources [1][2]. - The company has completed all necessary decision-making procedures, and the legal opinion confirms compliance with laws and regulations regarding the repurchase and cancellation [2].